Cantitate/Preț
Produs

Muscular Dystrophy: A Concise Guide

Editat de Raymond A. Huml
en Limba Engleză Paperback – 30 iul 2015
This practical and concise guide offers an overview of muscular dystrophy's complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.
Citește tot Restrânge

Preț: 34350 lei

Preț vechi: 36158 lei
-5% Nou

Puncte Express: 515

Preț estimativ în valută:
6574 6829$ 5461£

Carte tipărită la comandă

Livrare economică 28 ianuarie-03 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319173610
ISBN-10: 3319173618
Pagini: 150
Ilustrații: XXIV, 191 p. 43 illus., 30 illus. in color.
Dimensiuni: 155 x 235 x 104 mm
Greutate: 0.43 kg
Ediția:1st ed. 2015
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Public țintă

Professional/practitioner

Cuprins

1. Introduction to Muscular Dystrophy.- 2.Muscular Dystrophy: Historical Background and Types.- 3.FSHD: The Most Common Type of MD?.- 4.Duchenne and Becker Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms.- 5.An Overview of the Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms.- 6.Transition from Childhood to Adult in Patients with Muscular Dystrophy.- 7.Overview of Current Treatments for Muscular Dystrophy.- 8.Physical Therapy and Orthotic Devices for Patients with Muscular Dystrophy.- 9.Orthopedic Care of Children with Muscular Dystrophy.- 10.Global Regulatory Landscape.- 11.Key Challenges to the Approval of Products to Treat Patients with Muscular Dystrophy.- 12.Pharmaceutical Products and Non-Pharmaceutical Interventions as Potential Treatments for Patients with Muscular Dystrophy.- 13.US Patient Advocacy Groups.- 14.Global and National Patient Registries.- 15.Summary.- Index.

Notă biografică

Raymond A. Huml, MS, DVM, RAC, is Executive Director, Strategic Drug Development, in the Biosimilars Center of Excellence at Quintiles. He was recently the author of the SpringerBrief, Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional. He has recruited several prominent MD's to contribute chapters to Muscular Dystrophy: A Concise Guide.
 

Textul de pe ultima copertă

This practical and concise guide offers an overview of muscular dystrophy's (MD) complicated features, treatment options and general resources.  New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long-term patient care.  Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances.  Muscular Dystrophy: A Concise Guide offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.

Caracteristici

Provides an overview of muscular dystrophy's features and treatment options Clinical and scientific advances are presented along with the regulatory landscape for muscular dystrophy Concise and practical guide for healthcare professionals, pharmaceutical executives and patient advocacy groups